Question 1

Does Grantham, Mayo, Van Otterloo own AMRX stock?

Accepted Answer

No. Grantham, Mayo, Van Otterloo exited its AMRX (Amneal Pharmaceuticals) position in Q3 2023. Its Q2 2023 13F listed 23,100 shares worth $71,610.

Question 2

How many shares of AMRX does Grantham, Mayo, Van Otterloo own?

Accepted Answer

None since Q3 2023, when Grantham, Mayo, Van Otterloo exited the position. Its Q2 2023 13F listed 23,100 shares worth $71,610.

Question 3

What is Grantham, Mayo, Van Otterloo's AMRX position worth?

Accepted Answer

Grantham, Mayo, Van Otterloo's AMRX position was worth $71,610 in its Q2 2023 13F, before the exit in Q3 2023.

Question 4

Is Grantham, Mayo, Van Otterloo buying or selling AMRX?

Accepted Answer

In Q3 2023, Grantham, Mayo, Van Otterloo exited its entire AMRX position.

Question 5

When did Grantham, Mayo, Van Otterloo first buy AMRX?

Accepted Answer

Grantham, Mayo, Van Otterloo first reported AMRX in its Q3 2020 13F and listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2023-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$4.22	0
2023-Q2	Unchanged	23,100	0.0%	$71,610	0.0%	$3.10	0
2023-Q1	New	23,100	-	$32,109	0.0%	$1.39	27
2022-Q3	Exited	0	-100.0%	$0	0.0%	$2.02	0
2022-Q2	Unchanged	146,500	0.0%	$466,000	0.0%	$3.18	0
2022-Q1	Increased	146,500	+500.4%	$611,000	0.0%	$4.17	39
2021-Q4	New	24,400	-	$117,000	0.0%	$4.79	30
2021-Q1	Exited	0	-100.0%	$0	0.0%	$6.73	0
2020-Q4	Decreased	154,700	-29.1%	$707,000	0.0%	$4.57	0
2020-Q3	New	218,100	-	$846,000	0.0%	$3.88	34